PetMed Express ( PETS ) and subsidiaries, doing business as 1-800-PetMeds, is a leading nationwide pet pharmacy. The company markets its health products for dogs, cats, and horses direct to the consumer through national television, online, and direct mail advertising campaigns. We are downgrading PetMed Express from Buy to Hold and reducing our 6-month target price from $21 to $17. The company should continue to report solid results thanks to management s focus on increasing its market share a
PetMed Express Lowered to Hold – Analyst Blog
March 30th, 2009 · Comments Off · Main Content
Tags: Advertising Campaigns·Blog·Company Markets·Direct Mail Advertising·Dogs Cats·Doing Business·Focus·Health Products·Horses·Market Share·National Television·Pet Pharmacy·Petmed Express·Petmeds·Pets·Subsidiaries·Target Price
Penny Stocks Picks for March 2009 – Grab Your Easy Profit
March 1st, 2009 · Comments Off · Main Content
TOMORROW STOCKS: Six Stocks will be doubling tomorrow with 14 min of the market opening – grab your profit – [VIDEO PROOF] 1. ALTH 5.84 a share Target price 12.00 by 12/09 Allos Therapeutics, Inc. is a biopharmaceutical company that is focused on developing and commercializing small molecule drugs for the treatment of cancer. The Company’s lead product candidate, PDX (pralatrexate) an antifolate is in Phase 2 trial in patients with relapsed or refractory peripheral T-cell lymphoma. The Com
Tags: Allos Therapeutics Inc·Biopharmaceutical Company·Lymphoma·Molecule Drugs·Pdx·Penny Stocks Picks·Peripheral T Cell Lymphoma·Phase 2·Product Candidate·T Cell Lymphoma·Target Price·Treatment Of Cancer·Video Proof
